1 October we become SureStone CapitalSame team, same ABN. Our website and email addresses move to surestone.com.au.

Company Interview / Market Update | Sigma Healthcare, Wesfarmers, GQG Partners, Megaport, Core Lithium

Loading

Preparing video

Market Update | Sigma Healthcare, Wesfarmers, GQG Partners, Megaport, Core Lithium

Company Interview10 Jun, 2026

Sigma Healthcare (ASX:SIG), the owner of the Chemist Warehouse franchise, has confirmed it is among potential bidders for UK health and beauty retailer Boots. Sigma says it has engaged in preliminary discussions in relation to the sale process. However, it says there is no certainty that any transaction will eventuate. A report in the Financial Times said talks are at an early stage and no decision on the $14 billion sale had been made. Private equity firm Sycamore Partners, which last year took control of Boots through the acquisition of its parent company, Walgreens Boots Alliance, entered into discussions with potential strategic buyers before Easter, according to the report.

Wesfarmers (ASX:WES) expects to make a final investment decision on its Mt Holland lithium expansion in the first half of FY27. It has plans to double spodumene concentrate nameplate production. At its annual strategy day the conglomerate also said Bunnings has a pipeline of more than 100 property projects to FY30. Kmart is scaling agentic commerce and launching a third-party marketplace and Officeworks is executing a multi-year transformation focused on cost reduction and tech solutions. And it says Wesfarmers Health added 24 new Priceline Pharmacy sites in FY26.

Megaport (ASX:MP1) has selected VAST Data as the data platform provider for its global network and compute infrastructure. The move follows Megaport's purchase of Latitude.sh and as it seeks to capture growing demand for AI infrastructure services. The company says VAST's software will underpin enterprise data services across Megaport's network of more than 1100 data centres.

GQG Partners (ASX:GQG) has seen an outflow of funds so far this year of $11.9 billion dollars. However investment performance gains of $11.3 billion dollars partially offset the outflows. It says funds under management stood at $163.3 billion dollars at the end of May.

Core Lithium (ASX:CXO) has signed a binding agreement with Glencore to sell 25,000 tonnes of lithium fines from its Finniss operation in the Northern Territory. This is the second fines sale by Core in 2026, bringing total lithium sales revenue for the year to approximately A$28.5 million.

Copyright © 2026 Ausbiz Capital
Market Update | Sigma Healthcare, Wesfarmers, GQG Partners, Megaport, Core Lithium - Ausbiz Capital